The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Investor's Business Daily on MSN1h
Novo Nordisk Dives After Medicare Targets Ozempic, Wegovy For Price CutsNovo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback